P
Ecosystem Profile
ProteinQure
Computational infrastructure for developing new drugs.
1
Dispatches
May 30, 2026
Last Signal
Full Coverage Archive
Toronto Biotech’s Peptide Focus Challenges Quantum Hype: Why Classical AI Outperforms Q-Chemistry in Drug Design
AI InfrastructureMay 30, 20262 min
Toronto Biotech’s Peptide Focus Challenges Quantum Hype: Why Classical AI Outperforms Q-Chemistry in Drug Design
Mark Fingerhuth, co-founder and CDO at ProteinQure, provided a critical counterpoint to the prevailing excitement around quantum chemistry during Toronto Tech Week. While many industry voices suggest that simu...
↗ ProteinQure argues that for drug discovery, improving classical AI models to handle ‘messy biology’ is currently a greater determinant of success than achieving quantum chemistry simulations.